Nationwide International Index Fund Class R6 (GIXIX)
NASDAQ · Mutual Fund
· Delayed Price · Currency is USD
9.84
-0.09 (-0.91%)
Jun 20, 2025, 4:00 PM EDT
9.09% (1Y)
| Fund Assets | 1.57B |
| Expense Ratio | 0.29% |
| Min. Investment | $1,000,000 |
| Turnover | n/a |
| Dividend (ttm) | 0.37 |
| Dividend Yield | 3.72% |
| Dividend Growth | 26.43% |
| Payout Frequency | Semi-Annual |
| Ex-Dividend Date | Jun 9, 2025 |
| Previous Close | 9.93 |
| YTD Return | 16.13% |
| 1-Year Return | 13.53% |
| 5-Year Return | 62.40% |
| 52-Week Low | 8.32 |
| 52-Week High | 10.18 |
| Beta (5Y) | 0.84 |
| Holdings | 718 |
| Inception Date | Dec 29, 1999 |
About GIXIX
The Nationwide International Index Fund Class R6 (GIXIX) seeks to match the performance of the Morgan Stanley Capital International Europe, Asia and Far East Capitalization Weighted Index as closely as possible before the deduction of Fund expenses.
Fund Family Nationwide Fds R6
Category Foreign Large Blend
Stock Exchange NASDAQ
Ticker Symbol GIXIX
Share Class Class R6
Index MSCI EAFE NR USD
Performance
GIXIX had a total return of 13.53% in the past year, including dividends. Since the fund's inception, the average annual return has been 3.91%.
Top 10 Holdings
13.14% of assets| Name | Symbol | Weight |
|---|---|---|
| SAP SE | SAP | 1.71% |
| Nestlé S.A. | NESN | 1.59% |
| ASML Holding N.V. | ASML | 1.57% |
| Novartis AG | NOVN | 1.31% |
| Roche Holding AG | ROG | 1.30% |
| Novo Nordisk A/S | NOVO.B | 1.21% |
| AstraZeneca PLC | AZN | 1.21% |
| HSBC Holdings plc | HSBA | 1.14% |
| Shell plc | SHEL | 1.09% |
| Commonwealth Bank of Australia | CBA | 1.02% |
Dividend History
| Ex-Dividend | Amount | Pay Date |
|---|---|---|
| Jun 9, 2025 | $0.12682 | Jun 10, 2025 |
| Dec 19, 2024 | $0.20317 | Dec 20, 2024 |
| Sep 9, 2024 | $0.03597 | Sep 10, 2024 |
| Jun 10, 2024 | $0.12438 | Jun 11, 2024 |
| Dec 20, 2023 | $0.13938 | Dec 21, 2023 |
| Sep 11, 2023 | $0.0257 | Sep 12, 2023 |